Quadrant to float

Tuesday 06 January 1998 19:02 EST

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Quadrant to float

Quadrant Healthcare is to float to market next month in a move that will raise pounds 30m of new money. It will be used to develop new applications for trehalose, a special sugar that allows desert plants to bloom again after years of drought. Quadrant's techniques use the sugar to control the release of drugs into the bloodstream. Quadrant is expected to make a loss of pounds 3m in the current year, but chief executive Iain Ross is now focusing specifically on pharmaceuticals.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

Quadrant to float

Join our commenting forum

Thank you for registering